CONMED | CNMD - Selling And Administration Expenses



CONMED reported $124.89M in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.

Selling And Administration Expenses Change Date
3M USD 1.06B 866M Sep/2024
Abbott USD 2.89B 89M Sep/2024
AtriCure USD 73.24M 362K Sep/2024
Avanos Medical USD 74.3M 1.2M Sep/2024
Baxter International USD 754M 267M Sep/2024
Becton, Dickinson and Co. USD 1.26B 50M Sep/2024
Boston Scientific USD 1.56B 116M Sep/2024
CONMED USD 124.89M 6.33M Sep/2024
Cooper Companies USD 381.1M 800K Jul/2024
Dexcom USD 306.4M 26.3M Sep/2024
Edwards Lifesciences USD 421.4M 29.4M Sep/2024
Globus Medical USD 240.74M 2.62M Sep/2024
Hologic USD 249.2M 8.9M Sep/2024
Insulet USD 234.1M 11.7M Sep/2024
Integra LifeSciences USD 177.19M 18.28M Sep/2024
Intuitive Surgical USD 510.6M 14.7M Sep/2024
J&J USD 5.48B 29M Sep/2024
Masimo USD 184.8M 7.3M Sep/2024
Medtronic USD 2.64B 122M Jun/2024
Merit Medical Systems USD 99.64M 5.06M Sep/2024
Olympus JPY 119.07B 241M Sep/2024
ResMed USD 238.98M 3.21M Sep/2024
Smith & Nephew USD 754.5M 440.5M Jun/2024
Steris USD 329.3M 4.07M Sep/2024
Stryker USD 1.82B 31M Sep/2024
Tandem Diabetes Care USD 99.64M 5.4M Sep/2024
Teleflex USD 247.26M 5.41M Oct/2024
Zimmer Biomet Holdings USD 709.7M 27.4M Sep/2024